End-of-day quote
Korea S.E.
23:00:00 16/05/2024 BST
|
5-day change
|
1st Jan Change
|
1,790
KRW
|
+1.70%
|
|
+1.65%
|
-3.09%
|
04-26 |
INSAN Inc. announced that it expects to receive KRW 15 billion in funding from Mirae Asset Securities Co., Ltd., KB Securities Co.,Ltd, Samsung Securities Co.,Ltd., Korea Investment & Securities Co., Ltd., Shinhan Investment & Securities Co., Ltd.
|
CI
| 2023 |
INSAN Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
|
CI
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
38,909
|
50,763
|
51,869
|
67,457
|
57,564
|
70,457
|
Enterprise Value (EV)
1 |
36,654
|
47,154
|
59,910
|
68,675
|
73,907
|
71,795
|
P/E ratio
|
-35.2
x
|
16.4
x
|
11.5
x
|
10.3
x
|
15.5
x
|
14.5
x
|
Yield
|
1.26%
|
1.57%
|
2.55%
|
3.77%
|
2.25%
|
2.71%
|
Capitalization / Revenue
|
1.54
x
|
1.96
x
|
1.7
x
|
1.76
x
|
1.72
x
|
1.89
x
|
EV / Revenue
|
1.45
x
|
1.82
x
|
1.97
x
|
1.79
x
|
2.2
x
|
1.92
x
|
EV / EBITDA
|
7.11
x
|
8.32
x
|
8.01
x
|
6.7
x
|
11
x
|
9.16
x
|
EV / FCF
|
-
|
-18,253,569
x
|
-5,572,690
x
|
-14,776,213
x
|
-5,519,183
x
|
21,578,365
x
|
FCF Yield
|
-
|
-0%
|
-0%
|
-0%
|
-0%
|
0%
|
Price to Book
|
1.61
x
|
1.66
x
|
1.5
x
|
1.36
x
|
1.11
x
|
1.08
x
|
Nbr of stocks (in thousands)
|
24,471
|
26,508
|
26,464
|
31,819
|
32,339
|
38,147
|
Reference price
2 |
1,590
|
1,915
|
1,960
|
2,120
|
1,780
|
1,847
|
Announcement Date
|
18/03/19
|
16/03/20
|
08/03/21
|
14/03/22
|
13/03/23
|
11/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
25,232
|
25,864
|
30,465
|
38,308
|
33,538
|
37,300
|
EBITDA
1 |
5,153
|
5,669
|
7,484
|
10,252
|
6,688
|
7,839
|
EBIT
1 |
4,214
|
3,993
|
5,713
|
8,229
|
4,705
|
5,741
|
Operating Margin
|
16.7%
|
15.44%
|
18.75%
|
21.48%
|
14.03%
|
15.39%
|
Earnings before Tax (EBT)
1 |
-269.8
|
3,912
|
5,546
|
7,687
|
4,038
|
6,214
|
Net income
1 |
-951.1
|
3,130
|
4,682
|
6,327
|
3,775
|
4,969
|
Net margin
|
-3.77%
|
12.1%
|
15.37%
|
16.52%
|
11.26%
|
13.32%
|
EPS
2 |
-45.20
|
117.0
|
170.3
|
206.0
|
114.9
|
127.0
|
Free Cash Flow
|
-
|
-2,583
|
-10,751
|
-4,648
|
-13,391
|
3,327
|
FCF margin
|
-
|
-9.99%
|
-35.29%
|
-12.13%
|
-39.93%
|
8.92%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
42.45%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
66.95%
|
Dividend per Share
2 |
20.00
|
30.00
|
50.00
|
80.00
|
40.00
|
50.00
|
Announcement Date
|
18/03/19
|
16/03/20
|
08/03/21
|
14/03/22
|
13/03/23
|
11/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
8,041
|
1,218
|
16,344
|
1,338
|
Net Cash position
1 |
2,255
|
3,609
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
1.074
x
|
0.1188
x
|
2.444
x
|
0.1707
x
|
Free Cash Flow
|
-
|
-2,583
|
-10,751
|
-4,648
|
-13,391
|
3,327
|
ROE (net income / shareholders' equity)
|
-
|
11.5%
|
14.5%
|
15.1%
|
7.41%
|
8.48%
|
ROA (Net income/ Total Assets)
|
-
|
5.89%
|
6.21%
|
6.71%
|
3.35%
|
4.02%
|
Assets
1 |
-
|
53,114
|
75,354
|
94,309
|
112,799
|
123,645
|
Book Value Per Share
2 |
985.0
|
1,156
|
1,303
|
1,556
|
1,609
|
1,713
|
Cash Flow per Share
2 |
136.0
|
442.0
|
271.0
|
230.0
|
114.0
|
138.0
|
Capex
1 |
1,657
|
5,656
|
15,080
|
12,125
|
11,452
|
3,051
|
Capex / Sales
|
6.57%
|
21.87%
|
49.5%
|
31.65%
|
34.15%
|
8.18%
|
Announcement Date
|
18/03/19
|
16/03/20
|
08/03/21
|
14/03/22
|
13/03/23
|
11/03/24
|
|
1st Jan change
|
Capi.
|
---|
| -3.09% | 50.46M | | +16.86% | 8.43B | | +3.57% | 7.49B | | +4.89% | 6.23B | | -5.23% | 3.75B | | -6.58% | 3.75B | | -3.55% | 1.33B | | -28.64% | 1.09B | | +18.12% | 1.02B | | -8.60% | 933M |
Special Foods & Wellbeing Products
|